| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_NFATC3_0012800 | Exon-Exon | chr16:68215378-68217269 | chr16:68181475-68183366 | 183 nt | 0.4481 |
| hsa_NFATC3_0012900 | Exon-Exon | chr16:68215378-68225678 | chr16:68181475-68191775 | 1191 nt | 0.4593 |
| hsa_NFATC3_0013100 | Exon-Exon | chr16:68217143-68225678 | chr16:68183240-68191775 | 1135 nt | 0.4581 |
| hsa_NFATC3_0013300 | Exon-Exon | chr16:68224671-68225678 | chr16:68190768-68191775 | 1008 nt | 0.4613 |
| hsa_NFATC3_0001000 | Intron-Exon-Intron | chr16:68127259-68157024 | chr16:68093356-68123121 | 104 nt | 0.4327 |
| hsa_NFATC3_0001100 | Intron-Exon-Intron | chr16:68127259-68160513 | chr16:68093356-68126610 | 267 nt | 0.4419 |
| hsa_NFATC3_0000700 | Intron-Exon-Intron | chr16:68127259-68191971 | chr16:68093356-68158068 | 250 nt | 0.3360 |
| hsa_NFATC3_0001200 | Intron-Exon-Intron | chr16:68127259-68208417 | chr16:68093356-68174514 | 141 nt | 0.3830 |
| hsa_NFATC3_0000800 | Intron-Exon-Intron | chr16:68127259-68217269 | chr16:68093356-68183366 | 250 nt | 0.3400 |
| hsa_NFATC3_0001300 | Intron-Exon | chr16:68127259-68225678 | chr16:68093356-68191775 | 104 nt | 0.4327 |
A study in human peripheral whole blood samples selected the circNFATC3 for validation but eliminated it from the final age prediction model due to barely detectable expression (Ct >37) in RT-qPCR assays [Wang et al. DOI:10.3389/fgene.2022.1031806].